December 21, 2004
Flamel Technologies Announces Completion of a Commercial Supply
Agreement with Glaxo-Smith Kline for Drug in Phase III Trials
December 17, 2004
Flamel Technologies Announces Initiation of Phase I/II trial of Medusa Formulation of Long-Acting Interferon-alpha
for Hepatitis B and Hepatitis C Treatment
Flamel Technologies Announces Initiation of Phase I/II trial of Medusa Formulation of Long-Acting Interleukin-2 for Cancer Treatment
October 28, 2004
Flamel Technologies Announces Third
Quarter Results
Transcript
of the conference call
October 25, 2004
Flamel Technologies Announces Projected Release Date of Third
Quarter, Conference Call
September 16, 2004
Flamel Technologies Announces the License of Flamel's Micropump
Technology to TAP Pharmaceutical Products Inc. for Lansoprazole,
Conference Call
Webcast
September 16, 2004
Flamel Technologies Announces Initiation of Phase III trial for
Micropump Formulation of a GlaxoSmithKline Product, Conference
Call
Webcast
September 16, 2004
Flamel Technologies Announces Termination of License Agreement
for Long-Acting Insulin, Conference Call
Webcast
July 29, 2004
Flamel Technologies Announces Second Quarter Revenues of $9.0
Million, Cash at $101 Million
Webcast
for Q2 2004
Replay of the CC: (800) 642-1687 (US) or (706) 645-9291 (international)
conference ID: 8771969
Transcript
of the conference call
July 26, 2004
Flamel Technologies Announces Projected Release Date of Second
Quarter Results, Conference Call
July 1, 2004
Flamel Technologies Announces Selection of a Flamel Micropump
Formulation to Progress to Phase III Clinical Trials
April 29, 2004
Flamel Technologies Announces First Quarter Revenues of $14.4
Million, Earnings of $0.20 Per Share
April 26, 2004
Flamel Technologies Announces Projected Release Date of First
Quarter Results, Conference Call
April 1, 2004
Flamel Technologies announces receipt of $5 million milestone
payment from Bristol-Myers Squibb Company
March 11, 2004
Flamel Technologies announces fourth quarter and year end 2003
results
March 4, 2004
Flamel Technologies announces projected release date of fourth
quarter and year end results, conference call
January 5, 2004
Flamel Technologies announces receipt of milestone payment from
GlaxoSmithKline